SFS 2014:1033 Förordning om ändring i förordningen (1999:58) om förbud mot vissa hälsofarliga varor

141033.PDF

Källa Regeringskansliets rättsdatabaser m.fl.

<div><style type="text/css"> <!-- p {margin: 0; padding: 0;} .ft10{font-size:14px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft11{font-size:27px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft12{font-size:19px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft13{font-size:8px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft14{font-size:7px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft15{font-size:12px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft16{font-size:19px;line-height:19px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft17{font-size:14px;line-height:17px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft18{font-size:12px;line-height:14px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft19{font-size:12px;line-height:12px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft110{font-size:12px;line-height:15px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft20{font-size:14px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft21{font-size:15px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft22{font-size:14px;font-family:LKKHNL+TimesNewRomanPS;color:#000000;} .ft23{font-size:8px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft24{font-size:7px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft25{font-size:12px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft26{font-size:15px;line-height:17px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft27{font-size:14px;line-height:17px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft28{font-size:12px;line-height:14px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft30{font-size:14px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft31{font-size:15px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft32{font-size:8px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft33{font-size:14px;font-family:LKKHJJ+TimesNewRomanPS;color:#000000;} .ft34{font-size:12px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} .ft35{font-size:14px;line-height:17px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} --> <!-- p {margin: 0; padding: 0;} .ft40{font-size:8px;font-family:LKKHJI+TimesNewRomanPS;color:#000000;} --> </style> <div id="page1-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:646px;white-space:nowrap" class="ft10">1</p> <p style="position:absolute;top:80px;left:77px;white-space:nowrap" class="ft11"><b>Svensk f�rfattningssamling</b></p> <p style="position:absolute;top:189px;left:77px;white-space:nowrap" class="ft16"><b>F�rordning<br/>om �ndring i f�rordningen (1999:58) om f�rbud <br/>mot vissa h�lsofarliga varor;</b></p> <p style="position:absolute;top:265px;left:77px;white-space:nowrap" class="ft10">utf�rdad den 10 juli 2014.</p> <p style="position:absolute;top:299px;left:91px;white-space:nowrap" class="ft10">Regeringen f�reskriver</p> <p style="position:absolute;top:298px;left:224px;white-space:nowrap" class="ft13">1 att bilagan till f�rordningen (1999:58) om f�rbud</p> <p style="position:absolute;top:317px;left:77px;white-space:nowrap" class="ft10">mot vissa h�lsofarliga varor ska ha f�ljande lydelse.</p> <p style="position:absolute;top:353px;left:91px;white-space:nowrap" class="ft10">Denna f�rordning tr�der i kraft den 19 augusti 2014.</p> <p style="position:absolute;top:388px;left:77px;white-space:nowrap" class="ft10">P� regeringens v�gnar</p> <p style="position:absolute;top:422px;left:77px;white-space:nowrap" class="ft10">MARIA LARSSON</p> <p style="position:absolute;top:440px;left:307px;white-space:nowrap" class="ft17">Hans Hagelin<br/>(Socialdepartementet)</p> <p style="position:absolute;top:898px;left:77px;white-space:nowrap" class="ft19">1 Se Europaparlamentets och r�dets direktiv 98/34/EG av den 22 juni 1998 om ett in-<br/>formationsf�rfarande betr�ffande tekniska standarder och f�reskrifter och betr�ffande<br/>f�reskrifter f�r informationssamh�llets tj�nster.</p> <p style="position:absolute;top:175px;left:536px;white-space:nowrap" class="ft12"><b>SFS 2014:1033</b></p> <p style="position:absolute;top:202px;left:536px;white-space:nowrap" class="ft110">Utkom fr�n trycket<br/>den 22 juli 2014</p> </div> <div id="page2-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:46px;white-space:nowrap" class="ft20">2</p> <p style="position:absolute;top:51px;left:46px;white-space:nowrap" class="ft21"><b>SFS 2014:1033</b></p> <p style="position:absolute;top:51px;left:581px;white-space:nowrap" class="ft22"><i>Bilaga</i></p> <p style="position:absolute;top:49px;left:619px;white-space:nowrap" class="ft23">2</p> <p style="position:absolute;top:94px;left:181px;white-space:nowrap" class="ft26"><b>F�rteckning �ver varor som ska anses som h�lsofarliga varor <br/>enligt lagen om f�rbud mot vissa h�lsofarliga varor</b></p> <p style="position:absolute;top:138px;left:196px;white-space:nowrap" class="ft27">N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)<br/>1-(3,4-metylendioxifenyl)-2-butylamin (BDB)<br/>5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)<br/>5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)<br/>5-metoxi-alfametyltryptamin (5-MeO-AMT)<br/>2,5-dimetoxi-4-etylfenetylamin (2C-E)<br/>alfa-metyltryptamin (AMT)<br/>2,5-dimetoxi-4-klorfenetylamin (2C-C)<br/>2,5-dimetoxi-4-metylfenetylamin (2C-D)<br/>4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)<br/>4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)<br/>gammabutyrolakton (GBL)<br/>1,4-butandiol (1,4-BD)<br/>4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)<br/>4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)<br/>4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)<br/>4-hydroxi-N,N-dietyltryptamin (4-HO-DET)<br/>1-(3-trifluormetylfenyl)piperazin (TFMPP)<br/>2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)<br/>[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-bensoxa-</p> <p style="position:absolute;top:486px;left:181px;white-space:nowrap" class="ft20">zin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)</p> <p style="position:absolute;top:503px;left:196px;white-space:nowrap" class="ft20">5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol</p> <p style="position:absolute;top:520px;left:181px;white-space:nowrap" class="ft20">(CP 55,940)</p> <p style="position:absolute;top:538px;left:196px;white-space:nowrap" class="ft27">(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)<br/>(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)<br/>(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)<br/>2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)<br/>4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)<br/>1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)<br/>(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)<br/>4-metylhexan-2-amin (DMAA)<br/>4-(2-aminopropyl)bensofuran (4-APB)<br/>5-(2-aminopropyl)bensofuran (5-APB)<br/>6-(2-aminopropyl)bensofuran (6-APB)<br/>(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon</p> <p style="position:absolute;top:747px;left:181px;white-space:nowrap" class="ft20">(UR-144)</p> <p style="position:absolute;top:764px;left:196px;white-space:nowrap" class="ft27">1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:780px;left:407px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid</p> <p style="position:absolute;top:799px;left:181px;white-space:nowrap" class="ft20">(STS-135) </p> <p style="position:absolute;top:816px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:814px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indol-3-karboxamid</p> <p style="position:absolute;top:834px;left:181px;white-space:nowrap" class="ft20">(APICA [JWH-018 adamantyl karboxamid])</p> <p style="position:absolute;top:851px;left:196px;white-space:nowrap" class="ft20">1-pentyl-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:849px;left:351px;white-space:nowrap" class="ft23">3,7]dek-1-yl-1H-indazol-3-karboxamid</p> <p style="position:absolute;top:868px;left:181px;white-space:nowrap" class="ft20">(AKB48)</p> <p style="position:absolute;top:908px;left:181px;white-space:nowrap" class="ft28">2 Senaste lydelse 2013:790. �ndringen inneb�r bl.a. att 2-(IH-indol-5-yl)-metyl-<br/>etylamin (5-IT) tas bort ur f�rteckningen.</p> </div> <div id="page3-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:924px;left:649px;white-space:nowrap" class="ft30">3</p> <p style="position:absolute;top:51px;left:536px;white-space:nowrap" class="ft31"><b>SFS 2014:1033</b></p> <p style="position:absolute;top:51px;left:91px;white-space:nowrap" class="ft30">(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1</p> <p style="position:absolute;top:49px;left:320px;white-space:nowrap" class="ft32">3,7]dek-1-yl-metanon (AB-001)</p> <p style="position:absolute;top:68px;left:91px;white-space:nowrap" class="ft30">(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-</p> <p style="position:absolute;top:85px;left:77px;white-space:nowrap" class="ft30">anon (5F-UR-144<b>)</b></p> <p style="position:absolute;top:103px;left:91px;white-space:nowrap" class="ft35">1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)<br/>1-(5-fluoropentyl)-N-tricyklo[3.3.1.1</p> <p style="position:absolute;top:118px;left:303px;white-space:nowrap" class="ft32">3,7]dek-1-yl-1H-indazol-3-karbox-</p> <p style="position:absolute;top:138px;left:77px;white-space:nowrap" class="ft30">amid (5F-AKB48)</p> <p style="position:absolute;top:155px;left:91px;white-space:nowrap" class="ft30">1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018 </p> <p style="position:absolute;top:172px;left:77px;white-space:nowrap" class="ft30">N-[5-kloropentyl] derivat)</p> <p style="position:absolute;top:190px;left:91px;white-space:nowrap" class="ft30">N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-</p> <p style="position:absolute;top:207px;left:77px;white-space:nowrap" class="ft30">indazol-3-karboxamid (AB-FUBINACA)</p> <p style="position:absolute;top:225px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-</p> <p style="position:absolute;top:242px;left:77px;white-space:nowrap" class="ft30">indazol-3-karboxamid (ADB-FUBINACA)</p> <p style="position:absolute;top:259px;left:91px;white-space:nowrap" class="ft30">N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-indazol-3-</p> <p style="position:absolute;top:277px;left:77px;white-space:nowrap" class="ft30">karboxamid (AB-CHMINACA)</p> <p style="position:absolute;top:294px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid</p> <p style="position:absolute;top:312px;left:77px;white-space:nowrap" class="ft30">(AB-PINACA)</p> <p style="position:absolute;top:329px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-</p> <p style="position:absolute;top:346px;left:77px;white-space:nowrap" class="ft30">karboxamid (5F-AB-PINACA)</p> <p style="position:absolute;top:364px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karbox-</p> <p style="position:absolute;top:381px;left:77px;white-space:nowrap" class="ft30">amid (ADBICA)</p> <p style="position:absolute;top:399px;left:91px;white-space:nowrap" class="ft35">kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22)<br/>kinolin-8-yl-1-(4-flourobensyl)-1H-indol-3-karboxylat (FUB-PB-22)<br/>naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22)<br/>kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22 </p> <p style="position:absolute;top:468px;left:77px;white-space:nowrap" class="ft30">indazol)</p> <p style="position:absolute;top:486px;left:91px;white-space:nowrap" class="ft35">kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22)<br/>4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on </p> <p style="position:absolute;top:520px;left:77px;white-space:nowrap" class="ft30">(4-HTMPIPO)</p> <p style="position:absolute;top:538px;left:91px;white-space:nowrap" class="ft30">(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon </p> <p style="position:absolute;top:555px;left:77px;white-space:nowrap" class="ft30">(UR-144-heptylderivat)</p> <p style="position:absolute;top:573px;left:91px;white-space:nowrap" class="ft35">N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006)<br/>N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006)<br/>N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karbox-</p> <p style="position:absolute;top:625px;left:77px;white-space:nowrap" class="ft30">amid (ADB-PINACA)</p> <p style="position:absolute;top:642px;left:91px;white-space:nowrap" class="ft35">N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18)<br/>1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid</p> <p style="position:absolute;top:677px;left:77px;white-space:nowrap" class="ft30"> (5F-NNEI)</p> <p style="position:absolute;top:694px;left:91px;white-space:nowrap" class="ft30">N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-</p> <p style="position:absolute;top:712px;left:77px;white-space:nowrap" class="ft30">karboxamid (5F-AB-144)</p> <p style="position:absolute;top:729px;left:91px;white-space:nowrap" class="ft35">(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201)<br/>[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon<br/>(FUBIMINA)<br/>salvinorin A<br/>alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit ex-</p> <p style="position:absolute;top:816px;left:77px;white-space:nowrap" class="ft30">traherat och oavsett under vilka ben�mningar de f�rekommer </p> <p style="position:absolute;top:851px;left:91px;white-space:nowrap" class="ft30">Salter av �mnena n�r s�dana kan f�rekomma.</p> </div> <div id="page4-div" style="position:relative;width:701px;height:1028px;"> <img width="701" height="1028" src="/Static/i/lagboken/hidden.png" alt="background image"/> <p style="position:absolute;top:946px;left:529px;white-space:nowrap" class="ft40">Norstedts Juridik AB/Fritzes</p> <p style="position:absolute;top:956px;left:534px;white-space:nowrap" class="ft40">Elanders Sverige AB, 2014</p> </div> </div>
background image

1

Svensk f�rfattningssamling

F�rordning
om �ndring i f�rordningen (1999:58) om f�rbud
mot vissa h�lsofarliga varor;

utf�rdad den 10 juli 2014.

Regeringen f�reskriver

1 att bilagan till f�rordningen (1999:58) om f�rbud

mot vissa h�lsofarliga varor ska ha f�ljande lydelse.

Denna f�rordning tr�der i kraft den 19 augusti 2014.

P� regeringens v�gnar

MARIA LARSSON

Hans Hagelin
(Socialdepartementet)

1 Se Europaparlamentets och r�dets direktiv 98/34/EG av den 22 juni 1998 om ett in-
formationsf�rfarande betr�ffande tekniska standarder och f�reskrifter och betr�ffande
f�reskrifter f�r informationssamh�llets tj�nster.

SFS 2014:1033

Utkom fr�n trycket
den 22 juli 2014

background image

2

SFS 2014:1033

Bilaga

2

F�rteckning �ver varor som ska anses som h�lsofarliga varor
enligt lagen om f�rbud mot vissa h�lsofarliga varor

N-metyl-1-(3,4-metylendioxifenyl)-2-butylamin (MBDB)
1-(3,4-metylendioxifenyl)-2-butylamin (BDB)
5-metoxi-N,N-dimetyltryptamin (5-MeO-DMT)
5-metoxi-N,N-diisopropyltryptamin (5-MeO-DIPT)
5-metoxi-alfametyltryptamin (5-MeO-AMT)
2,5-dimetoxi-4-etylfenetylamin (2C-E)
alfa-metyltryptamin (AMT)
2,5-dimetoxi-4-klorfenetylamin (2C-C)
2,5-dimetoxi-4-metylfenetylamin (2C-D)
4-acetoxi-N,N-diisopropyltryptamin (4-AcO-DIPT)
4-hydroxi-N,N-diisopropyltryptamin (4-HO-DIPT)
gammabutyrolakton (GBL)
1,4-butandiol (1,4-BD)
4-acetoxi-N,N-metylisopropyltryptamin (4-AcO-MIPT)
4-hydroxi-N,N-metylisopropyltryptamin (4-HO-MIPT)
4-acetoxi-N,N-dietyltryptamin (4-AcO-DET)
4-hydroxi-N,N-dietyltryptamin (4-HO-DET)
1-(3-trifluormetylfenyl)piperazin (TFMPP)
2,5-dimetoxi-4-isopropyltiofenetylamin (2C-T-4)
[2,3-dihydro-5-metyl-3-(4-morfolinylmetyl)pyrrolo[1,2,3-de]-1,4-bensoxa-

zin-6-yl]-1-naftalenylmetanon (WIN 55,212-2)

5-(1,1-dimetylheptyl)-2-[5-hydroxy-2-(3-hydroxypropyl)cyclohexyl]fenol

(CP 55,940)

(2-metyl-1-pentylindol-3-yl)-(naftalen-1-yl)metanon (JWH-007)
(2-metyl-1-propyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-015)
(1-hexyl-1H-indol-3-yl)-1-naftalenylmetanon (JWH-019)
2-metylnaftalen-1-yl-(butylindol-3-yl)metanon (JWH-073 metylderivat)
4-metoxinaftalen-1-yl-(1-pentylindol-2-metyl-3-yl)metanon (JWH-098)
1-hexyl-2-fenyl-4-(1-naftoyl)pyrrol (JWH-147)
(4-metoxyfenyl)(1-pentyl-1H-indol-3-yl)metanon (RCS-4)
4-metylhexan-2-amin (DMAA)
4-(2-aminopropyl)bensofuran (4-APB)
5-(2-aminopropyl)bensofuran (5-APB)
6-(2-aminopropyl)bensofuran (6-APB)
(1-pentyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyclopropyl)metanon

(UR-144)

1-(1-bensofuran-5-yl)-N-metylpropan-2-amin (5-MAPB)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indol-3-karboxamid

(STS-135)

1-pentyl-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indol-3-karboxamid

(APICA [JWH-018 adamantyl karboxamid])

1-pentyl-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indazol-3-karboxamid

(AKB48)

2 Senaste lydelse 2013:790. �ndringen inneb�r bl.a. att 2-(IH-indol-5-yl)-metyl-
etylamin (5-IT) tas bort ur f�rteckningen.

background image

3

SFS 2014:1033

(1-pentyl-1H-indol-3-yl)tricyklo[3.3.1.1

3,7]dek-1-yl-metanon (AB-001)

(1-(5-fluoropentyl)-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)met-

anon (5F-UR-144)

1-(5-fluoropentyl)-1H-indol-3-karboxylsyra 8-kinolinester (5F-PB22)
1-(5-fluoropentyl)-N-tricyklo[3.3.1.1

3,7]dek-1-yl-1H-indazol-3-karbox-

amid (5F-AKB48)

1-[(5-kloropentyl)-1H-indol-3-yl]-(naftalen-1-yl)metanon (JWH-018

N-[5-kloropentyl] derivat)

N-[1-(aminokarbonyl)-2-metylpropyl]-1-[(4-fluorofenyl)metyl]-1H-

indazol-3-karboxamid (AB-FUBINACA)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-((4-fluorofenyl)metyl)-1H-

indazol-3-karboxamid (ADB-FUBINACA)

N-[1-(aminokarbonyl)-2-metylpropyl]-1-(cyclohexylmetyl)-1H-indazol-3-

karboxamid (AB-CHMINACA)

N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karboxamid

(AB-PINACA)

N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indazol-3-

karboxamid (5F-AB-PINACA)

N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indol-3-karbox-

amid (ADBICA)

kinolin-8-yl-1-pentyl-1H-indol-3-karboxylat (PB-22)
kinolin-8-yl-1-(4-flourobensyl)-1H-indol-3-karboxylat (FUB-PB-22)
naftalen-1-yl-1-(4-fluorobensyl)-1H-indol-3-karboxylat (FDU-PB-22)
kinolin-8-yl-1-(5-fluoropentyl)-1H-indazol-3-karboxylat (5F-PB-22

indazol)

kinolin-8-yl-1-(cyklohexylmetyl)-1H-indol-3-karboxylat (BB-22)
4-hydroxi-3,3,4-trimetyl-1-(1-pentyl-1H-indol-3-yl)pentan-1-on

(4-HTMPIPO)

(1-heptyl-1H-indol-3-yl)(2,2,3,3-tetrametylcyklopropyl)metanon

(UR-144-heptylderivat)

N-bensyl-1-(5-fluoropentyl)-1H-indol-3-karboxamid (5F-SDB-006)
N-bensyl-1-pentyl-1H-indol-3-karboxamid (SDB-006)
N-(1-amino-3,3-dimetyl-1-oxobutan-2-yl)-1-pentyl-1H-indazol-3-karbox-

amid (ADB-PINACA)

N-(naftalen-1-yl)-1-pentyl-1H-indazol-3-karboxamid (MN-18)
1-(5-fluoropentyl)-N-(naftalen-1-yl)-1H-indol-3-karboxamid

(5F-NNEI)

N-(1-amino-3-metyl-1-oxobutan-2-yl)-1-(5-fluoropentyl)-1H-indol-3-

karboxamid (5F-AB-144)

(1-(5-fluoropentyl)-1H-indazol-3-yl)(naftalen-1-yl)metanon (THJ-2201)
[1-(5-fluoropentyl)-1H-benso[d]imidazol-2-yl](naftalen-1-yl)metanon
(FUBIMINA)
salvinorin A
alla delar av v�xten Salvia divinorum fr�n vilka salvinorin A inte blivit ex-

traherat och oavsett under vilka ben�mningar de f�rekommer

Salter av �mnena n�r s�dana kan f�rekomma.

background image

Norstedts Juridik AB/Fritzes

Elanders Sverige AB, 2014

;